+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biochemistry Analyzers - Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139464
The global market for Biochemistry Analyzers was estimated at US$4.8 Billion in 2023 and is projected to reach US$6.9 Billion by 2030, growing at a CAGR of 4.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Clinical Diagnostics Application segment, which is expected to reach US$5.8 Billion by 2030 with a CAGR of 4.8%. The Drug Development Application segment is also set to grow at 5.3% CAGR for the next 8-year period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 4.5% CAGR to reach $1.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Biochemistry Analyzers Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biochemistry Analyzers Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Biochemistry Analyzers Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Arbor Biotechnologies, Inc., ARI Medical Technology Co., Ltd., Assure Tech. (Hangzhou) Co., Ltd, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 46 Featured):

  • Arbor Biotechnologies, Inc.
  • ARI Medical Technology Co., Ltd.
  • Assure Tech. (Hangzhou) Co., Ltd
  • Awareness Technology, Inc.
  • Bioevopeak Co., Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Cypress Diagnostics
  • CytoGene Research & Development
  • Diagnostic Automation / Cortez Diagnostics, Inc.
  • Erba Diagnostics Mannheim GmbH

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Biochemistry Analyzers - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Diseases Drives Demand for Biochemistry Analyzers
  • Technological Advancements in Automation and AI Propel Growth in Biochemistry Analyzer Efficiency
  • Expanding Point-of-Care Testing Market Throws the Spotlight on Portable Biochemistry Analyzers
  • Rising Adoption of Cloud-Based Data Management Systems Drives Adoption of Connected Analyzers
  • Surge in Personalized Diagnostics Accelerates Demand for High-Throughput Biochemistry Analyzers
  • Growing Importance of Early Disease Detection Sustain Growth in Clinical Laboratory Investments
  • Innovation in Microfluidic Technology Enhances Biochemistry Analyzer Capabilities
  • Demand for Rapid and High-Precision Testing Expands Opportunities for Next-Generation Analyzers
  • Advancements in Biomarker Discovery Drive Growth in Specialized Biochemistry Analyzer Segments
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Biochemistry Analyzers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Biochemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Bioreactor Byproduct Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Bioreactor Byproduct Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Bioreactor Byproduct Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Biochemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 29: USA Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: USA Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: USA 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 35: Canada Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Canada 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
JAPAN
  • Biochemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 41: Japan Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Japan 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
CHINA
  • Biochemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 47: China Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: China Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: China 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
EUROPE
  • Biochemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Biochemistry Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Biochemistry Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Biochemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Europe 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
FRANCE
  • Biochemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 59: France Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 62: France Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: France Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: France 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
GERMANY
  • Biochemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 68: Germany Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Germany 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 74: Italy Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: Italy 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Biochemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 80: UK Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: UK Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: UK 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Rest of Europe Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Rest of Europe 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of Europe Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Rest of Europe 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Biochemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Asia-Pacific Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Asia-Pacific 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Asia-Pacific Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Asia-Pacific 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 95: Rest of World Recent Past, Current & Future Analysis for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of World Historic Review for Biochemistry Analyzers by Application - Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of World 16-Year Perspective for Biochemistry Analyzers by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug Development, Bioreactor Byproduct Detection and Other Applications for the Years 2014, 2024 & 2030
  • Table 98: Rest of World Recent Past, Current & Future Analysis for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of World Historic Review for Biochemistry Analyzers by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Rest of World 16-Year Perspective for Biochemistry Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Academic & Research Institutes for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Arbor Biotechnologies, Inc.
  • ARI Medical Technology Co., Ltd.
  • Assure Tech. (Hangzhou) Co., Ltd
  • Awareness Technology, Inc.
  • Bioevopeak Co., Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Cypress Diagnostics
  • CytoGene Research & Development
  • Diagnostic Automation / Cortez Diagnostics, Inc.
  • Erba Diagnostics Mannheim GmbH

Table Information